Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGF-like family member 4 pseudogene is a non-protein-coding member of the insulin-like growth factor-like (IGFL) gene family, clustered on chromosome 19 alongside protein-coding IGFL genes and other pseudogenes. Like other processed pseudogenes, it arises from retrotransposition, lacks regulatory elements, and is generally considered non-functional, although pseudogenes can serve as regulatory RNA molecules, such as microRNA competitors, in some cases. There is no evidence that IGFL4 pseudogene is a receptor, enzyme, transporter, or therapeutic target in human disease. No structured information supports its use as a biomarker, drug target, or that it interacts with any clinical drugs. IGF-like family member 4 pseudogene (ENSG00000277748) is not a genuine therapeutic target; it is a human pseudogene with no evidence of protein expression or pharmacological relevance. Its canonical name is "IGF-like family member 4 pseudogene." It should not appear in drug target lists, and selecting it as a target would be incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IGF-like family member 4 pseudogene.